207 related articles for article (PubMed ID: 131847)
1. Neurochemistry of the mucopolysaccharidoses: brain glycosaminoglycans in normals and four types of mucopolysaccharidoses.
Constantopoulos G; McComb RD; Dekaban AS
J Neurochem; 1976 May; 26(5):901-8. PubMed ID: 131847
[No Abstract] [Full Text] [Related]
2. Neurochemistry of the mucopolysaccharidoses: brain glycosaminoglycans, lipids and lysosomal enzymes in mucopolysaccharidosis type III B (alpha-N-acetylglucosaminidase deficiency).
Constantopoulos G; Eiben RM; Schafer IA
J Neurochem; 1978 Nov; 31(5):1215-22. PubMed ID: 100580
[No Abstract] [Full Text] [Related]
3. Accumulation of intracellular amyloid-beta peptide (A beta 1-40) in mucopolysaccharidosis brains.
Ginsberg SD; Galvin JE; Lee VM; Rorke LB; Dickson DW; Wolfe JH; Jones MZ; Trojanowski JQ
J Neuropathol Exp Neurol; 1999 Aug; 58(8):815-24. PubMed ID: 10446806
[TBL] [Abstract][Full Text] [Related]
4. Characterization of glycosaminoglycans stored in mucopolysaccharidosis III A: evidence for a generally occuring degradation of heparan sulfate by endoglycosidases.
Kindler A; Klein U; von Figura K
Hoppe Seylers Z Physiol Chem; 1977 Nov; 358(11):1431-8. PubMed ID: 411726
[TBL] [Abstract][Full Text] [Related]
5. Chemical definition of the mucopolysaccharidoses.
Constantopoulos G; Dekaban AS
Clin Chim Acta; 1975 Mar; 59(3):321-36. PubMed ID: 123832
[TBL] [Abstract][Full Text] [Related]
6. The mucopolysaccharidoses (a review).
Dorfman A; Matalon R
Proc Natl Acad Sci U S A; 1976 Feb; 73(2):630-7. PubMed ID: 813230
[TBL] [Abstract][Full Text] [Related]
7. Mental retardation in mucopolysaccharidoses correlates with high molecular weight urinary heparan sulphate derived glucosamine.
Coppa GV; Gabrielli O; Zampini L; Maccari F; Mantovani V; Galeazzi T; Santoro L; Padella L; Marchesiello RL; Galeotti F; Volpi N
Metab Brain Dis; 2015 Dec; 30(6):1343-8. PubMed ID: 26016623
[TBL] [Abstract][Full Text] [Related]
8. [Characteristics of intracellular and excretory glycosaminoglycans in hereditary mucopolysaccharidoses].
Odinokova ON; Bialik MA; Krasnopol'skaia KD; Iakovlev SA
Vopr Med Khim; 1986; 32(1):87-92. PubMed ID: 3082072
[TBL] [Abstract][Full Text] [Related]
9. Demonstration of D-glucuronic acid as reducing terminal of intracellular heparan sulfates.
Klein U; von Figura K
FEBS Lett; 1976 Dec; 71(2):266-8. PubMed ID: 137126
[No Abstract] [Full Text] [Related]
10. Morphological and biochemical findings in a case of mucopolysaccharidosis type III A (Sanfilippo's disease type A).
Witting C; Müller KM; Kresse H; Figura KV; Marx H
Beitr Pathol; 1975; 154(3):324-38. PubMed ID: 805586
[TBL] [Abstract][Full Text] [Related]
11. Clinical heterogeneity in Sanfilippo disease (mucopolysaccharidosis III) type D: presentation of two new cases.
Coppa GV; Giorgi PL; Felici L; Gabrielli O; Donti E; Bernasconi S; Kresse H; Paschke E; Mastropaolo C
Eur J Pediatr; 1983 Apr; 140(2):130-3. PubMed ID: 6411475
[TBL] [Abstract][Full Text] [Related]
12. Mucopolysaccharides of brain and viscera in two cases of mucopolysaccharidosis [proceedings].
Van Dessel GA; Lagrou AR; Martin JJ; Dierick WS
Biochem Soc Trans; 1977; 5(4):1045-7. PubMed ID: 410678
[No Abstract] [Full Text] [Related]
13. Mucopolysaccharidosis type V. (Scheie syndrome). A postmortem study by multidisciplinary techniques with emphasis on the brain.
Dekaban AS; Constantopoulos G; Herman MM; Steusing JK
Arch Pathol Lab Med; 1976 May; 100(5):237-45. PubMed ID: 817693
[TBL] [Abstract][Full Text] [Related]
14. Mucopolysaccharidosis types IH, IS, II, and IIIA: glycosaminoglycans and lipids of isolated brain cells and other fractions from autopsied tissues.
Constantopoulos G; Iqbal K; Dekaban AS
J Neurochem; 1980 Jun; 34(6):1399-411. PubMed ID: 6770045
[No Abstract] [Full Text] [Related]
15. Heparan sulfate and dermatan sulfate from the liver of a patient with Hurler syndrome: high performance liquid chromatography of their degradation products after incubation with alpha-L-iduronidase-deficient fibroblasts.
Minami R; Fujibayashi S; Igarashi C; Ishikawa Y; Wagatsuma K; Nakao T; Tsugawa S
Clin Chim Acta; 1984 Feb; 137(2):179-87. PubMed ID: 6231139
[TBL] [Abstract][Full Text] [Related]
16. The biochemical basis for mucopolysaccharidoses and mucolipidoses.
Neufeld EF
Prog Med Genet; 1974; 10():81-101. PubMed ID: 4283415
[No Abstract] [Full Text] [Related]
17. A new biochemical subtype of the Sanfilippo syndrome: characterization of the storage material in cultured fibroblasts of Sanfilippo C patients.
Kresse H; Von Figura K; Klein U
Eur J Biochem; 1978 Dec; 92(2):333-9. PubMed ID: 153835
[TBL] [Abstract][Full Text] [Related]
18. Comments on the plasma treatment of the mucopolysaccharidoses.
Diferrante NM; Nicholds BL
Birth Defects Orig Artic Ser; 1974; 10(12):234-8. PubMed ID: 4218768
[No Abstract] [Full Text] [Related]
19. [Mucopolysaccharidoses. I. The clinical and radiological aspects of the 6 classical mucopolysaccharidoses].
Bulgarelli R; Romano C
Minerva Pediatr; 1972 Sep; 24(33):1471-578. PubMed ID: 4263584
[No Abstract] [Full Text] [Related]
20. Neurochemistry of the mucopolysaccharidoses: brain lipids and lysosomal enzymes in patients with four types of mucopolysaccharidosis and in normal controls.
Constantopoulos G; Dekaban AS
J Neurochem; 1978 May; 30(5):965-73. PubMed ID: 96217
[No Abstract] [Full Text] [Related]
[Next] [New Search]
